Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Curtis

Showing results (471-480 of 686) with videos related to

Pageof 69
Sort By:
Annals of Internal Medicine|May 3, 2016
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort StudyIsuru Ranasinghe, Craig S Parzynski, James V Freeman, et al.
Applied and Environmental Microbiology|July 9, 2014
Agreement between amoA gene-specific quantitative PCR and fluorescence in situ hybridization in the measurement of ammonia-oxidizing bacteria in activated sludgeJ D C Baptista, M Lunn, R J Davenport, et al.
Circulation. Arrhythmia and Electrophysiology|July 14, 2016
Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data RegistryEmily P Zeitler, Yongfei Wang, Kumar Dharmarajan, et al.
Circulation|September 9, 2017
Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment)Natalie Jayaram, John A Spertus, Kevin F Kennedy, et al.
The Journal of Rheumatology|February 17, 2007
Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trialHerbert S B Baraf, Carlos Fuentealba, Maria Greenwald, et al.
European Journal of Anaesthesiology|December 3, 1999
Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study GroupF Chung, R Lane, C Spraggs, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 31, 2023
Microstructural and Rheological Transitions in Bacterial BiofilmsSamuel G V Charlton, Amber N Bible, Eleonora Secchi, et al.
Health Services Research|August 12, 2010
What is the experience of national quality campaigns? Views from the fieldElizabeth H Bradley, Ingrid M Nembhard, Christina T Yuan, et al.
Journal of the American College of Cardiology|October 9, 2007
Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data RegistryBrahmajee K Nallamothu, Yongfei Wang, Elizabeth H Bradley, et al.
Journal of the American College of Cardiology|December 17, 2013
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)John A Dodson, Matthew R Reynolds, Haikun Bao, et al.
Pageof 69

Showing results (471-480 of 686) with videos related to

Sort By:
Pageof 69
Annals of Internal Medicine|May 3, 2016
Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort StudyIsuru Ranasinghe, Craig S Parzynski, James V Freeman, et al.
Applied and Environmental Microbiology|July 9, 2014
Agreement between amoA gene-specific quantitative PCR and fluorescence in situ hybridization in the measurement of ammonia-oxidizing bacteria in activated sludgeJ D C Baptista, M Lunn, R J Davenport, et al.
Circulation. Arrhythmia and Electrophysiology|July 14, 2016
Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data RegistryEmily P Zeitler, Yongfei Wang, Kumar Dharmarajan, et al.
Circulation|September 9, 2017
Modeling Major Adverse Outcomes of Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Catheterization: Observations From the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment)Natalie Jayaram, John A Spertus, Kevin F Kennedy, et al.
The Journal of Rheumatology|February 17, 2007
Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trialHerbert S B Baraf, Carlos Fuentealba, Maria Greenwald, et al.
European Journal of Anaesthesiology|December 3, 1999
Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study GroupF Chung, R Lane, C Spraggs, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 31, 2023
Microstructural and Rheological Transitions in Bacterial BiofilmsSamuel G V Charlton, Amber N Bible, Eleonora Secchi, et al.
Health Services Research|August 12, 2010
What is the experience of national quality campaigns? Views from the fieldElizabeth H Bradley, Ingrid M Nembhard, Christina T Yuan, et al.
Journal of the American College of Cardiology|October 9, 2007
Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data RegistryBrahmajee K Nallamothu, Yongfei Wang, Elizabeth H Bradley, et al.
Journal of the American College of Cardiology|December 17, 2013
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)John A Dodson, Matthew R Reynolds, Haikun Bao, et al.
Pageof 69